Study finds 25% of severe brain injury patients show cognitive awareness
HQ Team August 17, 2024: A new study reveals that one in four patients suffering from brain injury show some cognitive function during.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team August 17, 2024: A new study reveals that one in four patients suffering from brain injury show some cognitive function during.
HQ Team August 15, 2024: Sweden confirmed its first case of the most virulent form of Mpox Thursday, a viral infection found in.
HQ Team August15, 2024: A clinical trial has successfully restored hearing in five children suffering from inherited deafness by administering gene therapy to.
HQ Team August 14, 2024: Johnson & Johnson (J&J) is nearing settlement of lawsuits alleging that its talc-based baby powder caused cancer. Over.
HQ Team August 14, 2024: The Oropouche virus (OROV), primarily transmitted by biting midges (flies) and mosquitoes, is spreading in Latin America, with.
Pfizer Inc.’s vaccine trials on patients aged 18 and older with chronic respiratory diseases show a consistent safety profile and “strong neutralizing responses,”.
ARS Pharmaceuticals, a US-based biopharmaceutical company, got the nation’s drug regulator’s approval for a nasal spray to treat allergic reactions in adult and.
Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory.
When parents share unflattering or embarrassing images, it can lead to feelings of humiliation and a distorted self-image. Children may struggle with their.
Citius Pharmaceuticals, Inc., a US-based biotechnology company, got a green light from the country’s drug regulator for its immunotherapy treatment for a rare.